StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.25−0.03 (-9.88%)

Close on Nov 18, 2026Market cap $5.50MP/E –Yield –

Soligenix operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Soligenix's operating income for the twelve months ending Jun 30, 2026 was -$11.04M. For fiscal 2025 it was -$11.85M. The highest annual figure on record is -$2.96M in fiscal 2011.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.85M–
FY2024Dec 31, 2024-$9.44M–
FY2023Dec 31, 2023-$7.70M–
FY2022Dec 31, 2022-$14.24M–
FY2021Dec 31, 2021-$13.10M–
FY2020Dec 31, 2020-$18.59M–
FY2019Dec 31, 2019-$10.54M–
FY2018Dec 31, 2018-$9.06M–
FY2017Dec 31, 2017-$7.59M–
FY2016Dec 31, 2016-$5.71M–
FY2015Dec 31, 2015-$7.11M–
FY2014Dec 31, 2014-$10.76M–
FY2013Dec 31, 2013-$7.16M–
FY2012Dec 31, 2012-$4.69M–
FY2011Dec 31, 2011-$2.96M–
FY2010Dec 31, 2010-$7.88M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.10M–
Q1 FY2026Mar 31, 2026-$2.88M–
Q4 FY2025Dec 31, 2025-$3.47M–
Q3 FY2025Sep 30, 2025-$2.58M–
Q2 FY2025Jun 30, 2025-$2.76M–
Q1 FY2025Mar 31, 2025-$3.03M–
Q4 FY2024Dec 31, 2024-$3.71M–
Q3 FY2024Sep 30, 2024-$1.87M–
Q2 FY2024Jun 30, 2024-$1.74M–
Q1 FY2024Mar 31, 2024-$2.12M–
Q4 FY2023Dec 31, 2023-$2.14M–
Q3 FY2023Sep 30, 2023-$1.78M–
Q2 FY2023Jun 30, 2023-$1.63M–
Q1 FY2023Mar 31, 2023-$2.15M–
Q4 FY2022Dec 31, 2022-$3.57M–
Q3 FY2022Sep 30, 2022-$3.08M–
Q2 FY2022Jun 30, 2022-$3.40M–
Q1 FY2022Mar 31, 2022-$4.19M–
Q4 FY2021Dec 31, 2021-$4.51M–
Q3 FY2021Sep 30, 2021-$3.36M–
Q2 FY2021Jun 30, 2021-$2.99M–
Q1 FY2021Mar 31, 2021-$2.23M–
Q4 FY2020Dec 31, 2020-$5.49M–
Q3 FY2020Sep 30, 2020-$1.81M–
Q2 FY2020Jun 30, 2020-$2.81M–
Q1 FY2020Mar 31, 2020-$8.47M–
Q1 FY2019Mar 31, 2019-$2.30M–
Q4 FY2018Dec 31, 2018-$3.16M–
Q3 FY2018Sep 30, 2018-$1.92M–
Q2 FY2018Jun 30, 2018-$1.59M–
Q1 FY2018Mar 31, 2018-$2.39M–
Q4 FY2017Dec 31, 2017-$2.57M–
Q3 FY2017Sep 30, 2017-$969.62K–
Q2 FY2017Jun 30, 2017-$2.32M–
Q1 FY2017Mar 31, 2017-$1.74M–
Q4 FY2016Dec 31, 2016-$1.30M–
Q3 FY2016Sep 30, 2016-$1.50M–
Q2 FY2016Jun 30, 2016-$1.01M–
Q1 FY2016Mar 31, 2016-$1.91M–

More Soligenix figures

See a number that looks wrong?